We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.86M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.7M
3
CNR
Core Natural Resources Inc
CNR
+$8.26M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.63M
5
ORCL icon
Oracle
ORCL
+$6.25M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$14M
2
HTLF
Heartland Financial USA, Inc.
HTLF
+$11.1M
3
NVDA icon
NVIDIA
NVDA
+$9.36M
4
AMZN icon
Amazon
AMZN
+$8.75M
5
NFLX icon
Netflix
NFLX
+$8.58M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFG icon
376
Citizens Financial Group
CFG
$30.5B
$763K 0.06%
+18,626
New +$831K
PEN icon
377
Penumbra
PEN
$12.8B
$759K 0.06%
2,840
-712
-20% -$193K
NU icon
378
Nu Holdings
NU
$67B
$759K 0.06%
74,163
+19,163
+35% +$226K
ESGR
379
DELISTED
Enstar Group
ESGR
$759K 0.06%
2,284
-4,390
-66% -$1.45M
CLMT icon
380
Calumet Specialty Products
CLMT
$3.82B
$754K 0.06%
59,471
+37,263
+168% +$585K
BHVN icon
381
Biohaven
BHVN
$2.21B
$754K 0.06%
31,356
+22,953
+273% +$809K
TGI
382
DELISTED
Triumph Group
TGI
$753K 0.06%
+29,731
New +$688K
FMC icon
383
FMC
FMC
$1.29B
$752K 0.06%
17,813
+9,731
+120% +$432K
GUNR icon
384
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.07B
$750K 0.06%
+19,320
New +$737K
BCRX icon
385
BioCryst Pharmaceuticals
BCRX
$2.45B
$749K 0.06%
+99,900
New +$806K
NET icon
386
Cloudflare
NET
$109B
$747K 0.06%
+6,625
New +$878K
X
387
PUT
DELISTED
US Steel
X
$735K 0.06%
17,400
-13,900
-44% -$526K
FRSH icon
388
Freshworks
FRSH
$3.31B
$735K 0.06%
52,104
-19,632
-27% -$329K
RPD icon
389
Rapid7
RPD
$766M
$734K 0.06%
27,669
+2,866
+12% +$97.4K
TNDM icon
390
Tandem Diabetes Care
TNDM
$1.57B
$731K 0.06%
38,159
-59,531
-61% -$1.74M
MDLZ icon
391
Mondelez International
MDLZ
$78.4B
$730K 0.06%
+10,762
New +$663K
LPG icon
392
Dorian LPG
LPG
$1.93B
$728K 0.06%
32,606
-25,660
-44% -$594K
PBI icon
393
Pitney Bowes
PBI
$2.35B
$728K 0.06%
80,458
-21,719
-21% -$197K
CTRA
394
DELISTED
Coterra Energy
CTRA
$726K 0.06%
25,104
-11,608
-32% -$324K
ASPI icon
395
ASP Isotopes
ASPI
$540M
$721K 0.05%
153,770
+51,050
+50% +$255K
NVGS icon
396
Navigator Holdings
NVGS
$1.27B
$720K 0.05%
54,131
+13,577
+33% +$211K
LULU icon
397
lululemon athletica
LULU
$14.4B
$720K 0.05%
2,542
+1,630
+179% +$598K
VRN
398
DELISTED
Veren
VRN
$719K 0.05%
108,548
+58,548
+117% +$324K
MTZ icon
399
MasTec
MTZ
$21.9B
$716K 0.05%
6,134
+1,215
+25% +$164K
CAKE icon
400
Cheesecake Factory
CAKE
$5.48B
$714K 0.05%
14,667
-2,126
-13% -$109K
14 15
16
17 18

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.